Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas

Pathology and Oncology Research

Volumn 19, Issue 3, 2013, Pages 475-479

  Zhang, Kui ^a   Bai, Peng ^a   Shi, Shaoqing ^a   Zhou, Bin ^b   Wang, Yanyun ^b   Song, Yaping ^b   Rao, Li ^c   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Genetic susceptibility; Polymorphism; RTN4; Uterine Leiomyoma (UL)

Indexed keywords

ADENINE; CYTOSINE; THYMINE; 3' UNTRANSLATED REGION; MYELIN PROTEIN; PROTEIN NOGO;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHINESE; CHINESE HAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; POPULATION GENETICS; POSTMENOPAUSE; PREMENOPAUSE; RISK ASSESSMENT; RTN4 GENE; UTERUS MYOMA; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LEIOMYOMA; MIDDLE AGED; UTERUS CANCER;

3' UNTRANSLATED REGIONS; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEIOMYOMA; MIDDLE AGED; MYELIN PROTEINS; POLYMORPHISM, GENETIC; UTERINE NEOPLASMS;

EID: 84880329086     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9604-6     Document Type: Article

References (31)

1. Duhan N (2011) Current and emerging treatments for uterine myoma - an update. Int J Womens Health 3:231-241
2. Hart RKY, Yeong CT, Seed P, Taylor A, Braude P (2001) A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod 16:2411-2417
3. Ptacek TSC, Walker CL, Sell SM (2007) Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene. Cancer Genet Cytogenet 174:116-120
4. Morgan Ortiz FPRB, Elorriaga García E, Báez Barraza J, Quevedo Castro E, Peraza Garay Fde J (2011) Uterine leiomyomas during pregnancy and its impact on obstetric outcome. Ginecol Obstet Mex 79(8):467-473
5. Lee EJ, Kong G, Lee SH, Rho SB, Park CS, Kim BG, Bae DS, Kavanagh JJ, Lee JH (2005) Profiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer 15(1):146-154. doi: 10.1111/j.1048-891x.2005. 15016.x
6. Flynn MJM, Datta S, Myers E (2006) Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol 195(4):955-964
7. Luoto RKJ, Rutanen EM, Taipale P, Perola M, Koskenvuo M (2000) Heritability and risk factors of uterine fibroids-the Finnish Twin Cohort study. Maturitas 37(1):15-26
8. Chen Y, Tang X, Cao X, Chen H, Zhang X (2006) Human Nogo-C overexpression induces HEK293 cell apoptosis via a mechanism that involves JNK-c-Jun pathway. Biochem Biophys Res Commun 348(3):923-928. doi: 10.1016/j.bbrc.2006.07.166
9. Shimakage MIN, Ohshima K, Kawahara K, Oka T, Yasui K, Matsumoto K, Inoue H, Watari A, Higashiyama S, Yutsudo M (2006) Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma. Int J Cancer 119(7):1648-1653
10. Jung TYJS, Lee KH, Cao VT, Jin SG, Moon KS, Kim IY, Kang SS, Kim HS, Lee MC (2011) Nogo-A expression in oligodendroglial tumors. Neuropathology 31(1):11-19
11. Yicun Chen XT, Zhang X, Zhuang L (2009) New mutations of Nogo-C in hepatocellular carcinoma. Mol Biol Rep 36:377-380
12. Novak G, Tallerico T (2006) Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3'-UTR. Brain Res 1120(1):161-171. doi: 10.1016/j.brainres.2006.08.071
13. Novak G, Kim D, Seeman P, Tallerico T (2002) Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res Mol Brain Res 107(2):183-189
14. Zhou B, Rao L, Li Y, Gao L, Li C, Chen Y, Xue H, Liang W, Lv M, Song Y, Peng Y, Zhang L (2009) The association between dilated cardiomyopathy and RTN4 3'UTR insertion/deletion polymorphisms. Clin Chim Acta 400(1-2):21-24. doi: 10.1016/j.cca.2008.09.028
15. Chen Y, Zhou B, Li H, Peng Y, Wang Y, Rao L (2011) Analysis of RTN4 3'UTR insertion/deletion polymorphisms in ventricular septal defect in a Chinese Han population. DNA Cell Biol 30(5):323-327. doi: 10.1089/dna.2010.1116
16. Shi S, Zhou B, Wang Y, Chen Y, Zhang K, Wang K, Quan Y, Song Y, Rao L, Zhang L (2012) Genetic variation in RTN4 3'-UTR and susceptibility to cervical squamous cell carcinoma. DNA Cell Biol 31(6):1088-1094. doi: 10.1089/dna.2011.1548
17. Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928-1929
18. Wei TGA, Qian HR, Su C, Helvering LM, Kulkarini NH, Shou J, N'Cho M, Bryant HU, Onyia JE (2007) DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. BMC Womens Health 7:5
19. Hiroshi Ishikawa SR, Demura M, Rademaker AW, Kasai T, Inoue M, Usui H, Shozu M, Bulun SE (2009) High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab 94:1752-1756
20. Ishwad CSFR, Hanley K, Davare J, Meloni AM, Sandberg AA, Surti U (1997) Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosomes Cancer 19:156-160
21. Xing YPPW, Morton CC (1997) The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Cancer Genet Cytogenet 98(69-74):69
22. Meloni AMSU, Sandberg AA (1991) Deletion of chromosome 13 in leiomyomas of the uterus. Cancer Genet Cytogenet 53:199-203
23. Jennelle C, Hodge KTC, Huyck KL, Somasundaram P, Panhuysen CIM, Stewart EA, Morton CC (2009) Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet 125(3):257-263
24. Bowden WSJ, Kovanci E, Rajkovic A (2009) Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays. Mol Hum Reprod 15(9):563-568
25. Yaqin Chen SZ, Xiang R (2010) RTN3 and RTN4: candidate modulators in vascular cell apoptosis and atherosclerosis. J Cell Biochem 111:797-800
26. Oertle T, Huber C, van der Putten H, Schwab ME (2003) Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol 325(2):299-323
27. Yang J, Yu L, Bi AD, Zhao SY (2000) Assignment of the human reticulon 4 gene (RTN4) to chromosome 2p14-2p13 by radiation hybrid mapping. Cytogenet Cell Genet 88(1-2):101-102
28. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403(6768):439-444. doi: 10.1038/35000226
29. Chen YC, Lu DD, Cao XR, Zhang XR (2005) RTN4-C gene expression in hepatocellular carcinoma and its influence on SMMC7721 cell growth and apoptosis. Yi Chuan Xue Bao 32(9):891-897
30. Zheng H, Xue S, Lian F, Wang YY (2011) A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway. Med Hypotheses 77(2):278-281. doi: 10.1016/j.mehy.2011.04.035
31. Watari A, Yutsudo M (2003) Multi-functional gene ASY/Nogo/RTN-X/RTN4: apoptosis, tumor suppression, and inhibition of neuronal regeneration. Apoptosis 8(1):5-9